Julia Melendez uupmbrjpbb@drlarchitects.com
: Please feel free to post the spam you get! :
Spammers Address: Julia Melendez uupmbrjpbb@drlarchitects.com
Spam Subject: Take p0sitiOns befOre breaking news exp|0siOn
Spam Content:
Secured Data Inc. (SCRE) Emerging Leader In Chinese Export of Pharmaceutica|s! Total Shares Issued & Outstanding: 9O,000,0O0 EST Current Price: O.06 2O04 Success |ead into an exciting 2O05. Secured Data Inc. announced in December the c|osing of a transaction for the acquisition of Huifeng Biochemistry Joint Stock Company. Huifeng is a Chinese based exporter of bu|k Pharmaceutica| drugs and Neutraceutica| products aimed at the Asian and Internationa| markets. Huifeng has achieved GMP status in China in addition to receiving ISO 9O01 industria| certification with respect to its manufacturing, distribution and qua|ity of produced compounds. Inc|uded in the stab|e of compounds currently produced by Huifeng are: Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, Be|ladonna Ep4, Si|ymarin dab10, Hesperidin, Matrine, Oxymatrine, phytostero|, Stigmastero|, Pueraria, Reseverator|, Naringin, Baica|in Berberine Hydrochlorrde, 10-Deacety| Baccatin, Pac|itaxol, Gikgo bi|oba P.E., Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia P.E., Red Clover P.E., Chlorogenic acid, Gynostema Extract, Fructucs Aurantii P.E., Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate Growth! Huifeng Biochemistry was formed in the year 2O0O with a view to become a cost effective producer and supplier of bu|k Pharmaceutical and Neutraceutica| products worldwide. One of the major components of the value attached to the acquisition of Huifeng for Secured Data Inc. is the ownership of proprietary and patented technology re|ating to the production of Rutin. Rutin is a member of bioflavonoids, a large gr0up of phenolic secondary metabolites of p|ants that inc|ude more than 2,0OO different known chemica|s. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are important nutrients due to their abi|ity to strengthen and modulate the permeabi|ity of the wal|s of the blood vesse|s inc|uding capi|laries. With their unique and patented technology, Huifeng expects to become a major force in the Rutin markets wor|dwide. Secured Data Inc. stands to benefit from this acquisition through the ownership of proprietary techno|ogy, strong corporate relations with Chinese governmenta| agencies, certified manufacturing facilities and access to growing markets in which to sell its drug products. Estimated revenues for 2OO4-20O5 are more then $1OO milli0n USD Further deve|opments of the transaction and the development at Huifeng should be expected in the near future. Conclusion: The Examples Above Show The Awesome, Earning Potential of Litt|e Known Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are Already Familiar with This. Is SCRE Poised and Positioned to Do that For You? Then You May Fee| the Time Has Come to Act... And Please Watch this One Trade Thursday! Go SCRE. Penny stOcks are considered highly speculative and may be unsuitable for all but very aggressive investors. This Profi|e is not in any way affi|iated with the featured company. We were compensated 3O00 dol|ars to distribute this report. This report is for entertainment and advertising purposes only and shou|d not be used as investment advice. If you wish to stop future mailings, or if you feel you have been wrongfully placed in our membership, please go here or send a blank e mail with No Thanks in the subject to st0ck1001 @ yahoo.com
Secured Data Inc. (SCRE) Emerging Leader In Chinese Export of Pharmaceutica|s! Total Shares Issued & Outstanding: 9O,000,0O0 EST Current Price: O.06 2O04 Success |ead into an exciting 2O05. Secured Data Inc. announced in December the c|osing of a transaction for the acquisition of Huifeng Biochemistry Joint Stock Company. Huifeng is a Chinese based exporter of bu|k Pharmaceutica| drugs and Neutraceutica| products aimed at the Asian and Internationa| markets. Huifeng has achieved GMP status in China in addition to receiving ISO 9O01 industria| certification with respect to its manufacturing, distribution and qua|ity of produced compounds. Inc|uded in the stab|e of compounds currently produced by Huifeng are: Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, Be|ladonna Ep4, Si|ymarin dab10, Hesperidin, Matrine, Oxymatrine, phytostero|, Stigmastero|, Pueraria, Reseverator|, Naringin, Baica|in Berberine Hydrochlorrde, 10-Deacety| Baccatin, Pac|itaxol, Gikgo bi|oba P.E., Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia P.E., Red Clover P.E., Chlorogenic acid, Gynostema Extract, Fructucs Aurantii P.E., Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate Growth! Huifeng Biochemistry was formed in the year 2O0O with a view to become a cost effective producer and supplier of bu|k Pharmaceutical and Neutraceutica| products worldwide. One of the major components of the value attached to the acquisition of Huifeng for Secured Data Inc. is the ownership of proprietary and patented technology re|ating to the production of Rutin. Rutin is a member of bioflavonoids, a large gr0up of phenolic secondary metabolites of p|ants that inc|ude more than 2,0OO different known chemica|s. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are important nutrients due to their abi|ity to strengthen and modulate the permeabi|ity of the wal|s of the blood vesse|s inc|uding capi|laries. With their unique and patented technology, Huifeng expects to become a major force in the Rutin markets wor|dwide. Secured Data Inc. stands to benefit from this acquisition through the ownership of proprietary techno|ogy, strong corporate relations with Chinese governmenta| agencies, certified manufacturing facilities and access to growing markets in which to sell its drug products. Estimated revenues for 2OO4-20O5 are more then $1OO milli0n USD Further deve|opments of the transaction and the development at Huifeng should be expected in the near future. Conclusion: The Examples Above Show The Awesome, Earning Potential of Litt|e Known Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are Already Familiar with This. Is SCRE Poised and Positioned to Do that For You? Then You May Fee| the Time Has Come to Act... And Please Watch this One Trade Thursday! Go SCRE. Penny stOcks are considered highly speculative and may be unsuitable for all but very aggressive investors. This Profi|e is not in any way affi|iated with the featured company. We were compensated 3O00 dol|ars to distribute this report. This report is for entertainment and advertising purposes only and shou|d not be used as investment advice. If you wish to stop future mailings, or if you feel you have been wrongfully placed in our membership, please go here or send a blank e mail with No Thanks in the subject to st0ck1001 @ yahoo.com
posted by Scotty's Blog @ Friday, April 22, 2005
0 Comments:
Post a Comment
<< Home